US Rx painkiller overdoses on the rise

28 September 2008

Research presented at the USA's National Safety Council meeting in Anaheim, California, has revealed that, unlike many other causes of accidental death, overdoses triggered by prescription painkillers have shown a dramatic increase, rising 100% from 2000 to 2006. Janet Froetscher, the Council's president, told WebMD.com that there is a false perception that the problem is caused by "kids getting into the medicine cabinet," a view reinforced by federal government campaigns to raise awareness of the issue (Marketletter February 25).

Using data from the Centers for Disease Control and Prevention (CDC), Dr Froetscher told delegates that the biggest increase in accidental poisonings occurred in the 45-64 years age group over the previous 10 years. The rate of increase in the 25-44 years population was also higher than for 15-24-year-olds. The painkillers most likely to be associated with overdoses were buprenorphone, fentanyl, hydrocodone, methadone and oxycodone. The CDC figures also confirm that two illegal narcotics, cocaine and heroin, between them account for 39% of deaths, while prescription opiod drug abuse is blamed for 38%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight